Company Filing History:
Years Active: 2009
Title: Innovations in Drug Delivery: The Contributions of Chris Breuer
Introduction: Chris Breuer, based in Bethany, CT, is a prominent inventor recognized for his significant contributions to the field of biomedical engineering. With one patented invention, Breuer has made strides in improving therapeutic applications through innovative drug delivery systems.
Latest Patents: Breuer's patent, titled "Methods of treatment with drug loaded polymeric materials," revolves around the development of polymeric microparticles designed to encapsulate therapeutic compounds, including drugs and cellular materials. These microparticles feature targeting ligands that are directly bound to their surfaces, enhancing their efficacy. The applications of this technology are diverse, spanning tissue engineering matrices, wound dressings, and bone repair materials. Additionally, Breuer's innovation offers potential in delivering anti-proliferative agents to vascular linings after procedures like angioplasty to prevent restenosis and in treatments for conditions such as macular degeneration.
Career Highlights: Chris Breuer works at Yale University, where he applies his expertise in biomedical engineering to research and develop advanced materials for medical applications. His work focuses on bridging the gap between engineering and medicine, aiming to address critical challenges faced in patient care.
Collaborations: Throughout his career, Breuer has collaborated with esteemed colleagues, including William Mark Saltzman and Tarek M. Fahmy. These partnerships reflect a commitment to interdisciplinary research, enhancing the impact of their collective expertise in developing innovative solutions in healthcare.
Conclusion: Chris Breuer exemplifies the spirit of innovation in the biomedical field with his groundbreaking patent on drug delivery systems using polymeric microparticles. His ongoing work at Yale University continues to push the boundaries of how treatments can be safely and effectively delivered to patients, promising significant advancements in medical technology.